Compare Airbnb, Inc. (ABNB) vs BridgeBio Pharma Inc (BBIO) Price & Performance

Airbnb, Inc.Trade

BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

Airbnb, Inc. vs BridgeBio Pharma Inc — how do they compare? Airbnb, Inc. trades at $184.79 (market cap $110.76B), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: Airbnb, Inc. is far larger — about 6.8× BridgeBio Pharma Inc's market cap, and Airbnb, Inc. is trading nearer its 52-week high, BridgeBio Pharma Inc nearer its low. Which is the better fit depends on your goals.

	ABNB	BBIO
Market Cap	$110.76B	$16.36B
Sector	Consumer Cyclical	Health
52-Week High	$184.98	$90.17
52-Week Low	$111.54	$47.29
Enterprise Value	$101.19B	$18.14B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABNB

Airbnb stock hits new high on strong Q2 results and AI-driven growth strategyAndrew Wynn · 4 days agoBullish Airbnb stock jumps 15% after strong growth quarter driven by AI innovationsNew York Post · 4 days agoBullish Airbnb cuts feature launch time by 60% using AI, boosting product development and customer support efficiency.TechCrunch · 4 days agoBullish View details →

BBIO

BridgeBio beats Q2 estimates, confirms $1B+ 2026 sales goal and plans three product launches by 2027.Seeking Alpha · 21 hours agoBullish View details →

About Airbnb, Inc.

Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.